Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros








Intervalo de ano de publicação
1.
Gynecol Oncol ; 187: 74-79, 2024 May 10.
Artigo em Inglês | MEDLINE | ID: mdl-38733955

RESUMO

OBJECTIVE: Hysterectomy has been the historical gold standard final step in the treatment algorithm of adenocarcinoma in situ (AIS) recommended by most North American colposcopy guidelines. AIS disproportionately affects young childbearing age women, therefore a fertility sparing treatment option is desirable. Our study examines the impact of conservative treatment of AIS with conization followed by serial surveillance. METHODS: A retrospective chart review was completed of patients treated for AIS from 2006 to 2020. Charts were identified by pathologic diagnosis of AIS on cervical and uterine specimens. Charts were excluded if AIS was not treated with conization, if AIS was not confirmed on initial conization specimen, or if invasive disease was found at initial conization. RESULTS: 121 patient charts were analyzed. Median age of patients at first conization and hysterectomy was 34.8 and 40.9, respectively. First conization was by Cold Knife Cone in 58% of patients, and by Loop Electrosurgical Excisional Procedure in 42% of patients. Median follow-up period in our study was 609 days. 5% of patients had recurrence, with only one patient who recurred as cancer. One case of recurrence had a positive initial conization margin. Median time to recurrence was 700 days. 47% of patients underwent eventual hysterectomy. Residual AIS was found in 23% of hysterectomy specimens. Adenocarcinoma was diagnosed on hysterectomy specimen in four patients. CONCLUSION: Our study demonstrates the oncologic safety of treating AIS with conization and serial surveillance. Routine hysterectomy completed as a part of the AIS treatment algorithm, as in current clinical guidelines, is unnecessary.

4.
5.
MMW Munch Med Wochenschr ; 121(46): 1527-3, 1979 Nov 16.
Artigo em Alemão | MEDLINE | ID: mdl-117340

RESUMO

The differential diagnostic importance of CHE determination in searching for and observing the course of liver diseases is emphasized in the literature within the small and large enzyme pattern (eg. Gergs 1976). In chronic hepatitis and cirrhosis normal or almost normal values suggest a favorable prognosis. Greatly reduced CHE points to limitation of liver function and a severe form of the disease suggesting toxic influences and considerable deficiency. Rapidly falling CHE activity both in acute hepatitis and in chronic inflammations of the liver point to the danger of threatening hepatic coma.


Assuntos
Colinesterases/sangue , Hepatopatias/diagnóstico , Doenças Biliares/enzimologia , Fatores de Coagulação Sanguínea/análise , Butirilcolinesterase/metabolismo , Colinesterases/deficiência , Colinesterases/metabolismo , Ciclofosfamida/farmacologia , Dispneia/induzido quimicamente , Inibidores Enzimáticos , Hepatite/enzimologia , Humanos , Hiperbilirrubinemia/enzimologia , Inseticidas/intoxicação , Cirrose Hepática/enzimologia , Neoplasias Hepáticas/enzimologia , Neostigmina/farmacologia , Fisostigmina/farmacologia , Prognóstico , Succinilcolina/efeitos adversos , Tubocurarina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA